Inventor · disambiguated record
Xiefan Lin-Schmidt
Also filed as: LIN-SCHMIDT XIEFAN
9 granted patents·11 pending applications·22 citations·filing 2014–2025
84Inventor score
Top patents by PatentIndex Score
20 records- 0189US10336812B2GDF15 fusion proteins and uses thereofJANSSEN BIOTECH INC·Filed 2017·Granted Jul 2, 2019·11 cites·18 claims
- 0287US11208464B2GDF15 fusion proteins and uses thereofJANSSEN BIOTECH INC·Filed 2019·Granted Dec 28, 2021·4 cites·20 claims
- 0385US10759854B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2019·Granted Sep 1, 2020·2 cites·13 claims
- 0483US11713345B2Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Aug 1, 2023·2 cites·11 claims
- 0580US12275770B2Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion proteins and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Granted Apr 15, 2025·0 cites·15 claims
- 0678US10208113B2Interferon α and ω antibody antagonistsJANSSEN BIOTECH INC·Filed 2015·Granted Feb 19, 2019·2 cites·19 claims
- 0776US10358491B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2018·Granted Jul 23, 2019·1 cites·8 claims
- 0869US2025197468A1Glucagon like peptide 1 (glp1)-growth differentiation factor 15 (gdf15) fusion proteins and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2025·Application pending·0 cites
- 0968US2023119382A1Gdf15 fusion proteins and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1067US2025188163A1Gprc5d antibodies with enhanced effector function and uses thereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1161US9902770B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2014·Granted Feb 27, 2018·0 cites·15 claims
- 1260US2025230254A1Biosynthetic bioparatopic or bispecific binding molecules with enhanced effector functionsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1360US2025011454A1Biosynthetic monovalent binding molecules with enhanced effector functionsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1459US10155809B2Interferon alpha and omega antibody antagonistsJANSSEN BIOTECH INC·Filed 2017·Granted Dec 18, 2018·0 cites·4 claims
- 1556US2024182582A1Materials and methods for immune effector cells redirectionJANSSEN BIOTHECH INC·Filed 2022·Application pending·0 cites
- 1656US2019135912A1Interferon Alpha and Omega Antibody AntagonistsJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 1755US2022324970A1Materials and methods for multidirectional biotransportationJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1855US2023019640A1Materials and methods for polymeric antibody receptor targetingJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 1936US2019234935A1Methods for screening for modulators of gdf15-like biological activityJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 2034US2018355043A1Antibodies Specifically Binding HLA-DR and Their UsesJANSSEN BIOTECH INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiefan Lin-Schmidt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →